Stempoint Capital »

Surrozen shares owned by Stempoint Capital

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 183k 11.98
2024-06-30 $1.6M 144k 10.95

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Merus N V (MRUS)
Arcutis Biotherapeutics (ARQT)
Amicus Therapeutics (FOLD)
Applied Therapeutics (APLT)
Bristol Myers Squibb (BMY)
Crinetics Pharmaceuticals In (CRNX)
Biohaven (BHVN)
Praxis Precision Medicines I Com New (PRAX)
Autolus Therapeutics Spon Ads (AUTL)
Incyte Corporation (INCY)
Denali Therapeutics (DNLI)
Day One Biopharmaceuticals I (DAWN)

View all positions for Stempoint Capital

Top funds holding Surrozen

RA Capital Management
Armistice Capital
Nantahala Capital Management
Stempoint Capital
Stonepine Capital Management
Euclidean Capital
CVI Holdings
Vanguard Group
Arrowpoint Asset Management
Board of Trustees of The Leland Stanford Junior University
Morgan Stanley
Heights Capital Management
T. Rowe Price Associates
Alyeska Investment Group
Geode Capital Management

View all funds holding Surrozen